Mezzion Secures Strategic Financing to Support Advancement of Global Phase 3 FUEL-2 Trial in Fontan Patients

B Institutional financing supports continued execution of late-stage program evaluating JURVIGO® (udenafil) in patients living with Fontan circulation FORT LEE, N.J., May 14, 2026 /PRNewswire/…
posteditor
posteditor
Articles: 17424

Other News